A6MFL0

PR
Gene name
Protein name
L-amino-acid oxidase
Names
DvLAAO, LAO
Species
Demansia vestigiata (Lesser black whip snake) (Demansia atra)
KEGG Pathway
EC number
1.4.3.2: With oxygen as acceptor
Protein Class

Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

467-517 (Predicted disordered autoinhibitory region) PR

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

References

Autoinhibited structure

Activated structure

1 structures for A6MFL0

Entry ID Method Resolution Chain Position Source
AF-A6MFL0-F1 Predicted AlphaFoldDB

No variants for A6MFL0

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for A6MFL0

No associated diseases with A6MFL0

1 regional properties for A6MFL0

Type Name Position InterPro Accession
domain Amine oxidase 62 - 499 IPR002937

Functions

Description
EC Number 1.4.3.2 With oxygen as acceptor
Subcellular Localization
  • Secreted
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

2 GO annotations of molecular function

Name Definition
L-amino-acid oxidase activity Catalysis of the reaction: a L-amino acid + H2O + O2 = a 2-oxo acid + NH3 + hydrogen peroxide.
toxin activity Interacting selectively with one or more biological molecules in another (target) organism, initiating pathogenesis (leading to an abnormal, generally detrimental state) in the target organism. The activity should refer to an evolved function of the active gene product, i.e. one that was selected for. Examples include the activity of botulinum toxin, and snake venom.

3 GO annotations of biological process

Name Definition
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
defense response to bacterium Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
hemolysis in another organism The cytolytic destruction of red blood cells, with the release of intracellular hemoglobin, in one organism by another.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MNVFFMFSLL FLAALESCAD DRRNPLGECF READYEEFVD IATNGLKQTS NPKRVVVVGA
70 80 90 100 110 120
GMAGLSAAYV LAGAGHNVML LEASERVGGR VNTYRNEQEG WYVNLGPMRL PERHRIVREY
130 140 150 160 170 180
IKKFGLQLNQ FFQEDEDAWY FIKNIRKKVR EVKENPSIFP YPVKPSEKGK SAPQLYRDSL
190 200 210 220 230 240
QKIIEEYGRS NCSYILNKYD TYSTKDYLIK EGNLSPGAVD MIGDLLNEGS SYYLSFIESL
250 260 270 280 290 300
KSDDIFSYEN RFDEIVGGFD LLPKAMYKAI EEKVHLNARV IQIQQNAEGV RVTYQTPAKN
310 320 330 340 350 360
LSYVTADYVI VCSTSRAARR IYFEPPLPPE KAHALQSIHY RSATKIFLTC TKKFWEDDGI
370 380 390 400 410 420
HGGKSITDRP SRLIHYPNHN FPNGIGVLVI YTIADDADFF LALDNKTIAD IVIHDLSLIH
430 440 450 460 470 480
QLPKEKIRDL CYVSMIKKWS LDKYSMGSIT TFAPYQFQEY FETVAAPVGR IYFAGEYTAR
490 500 510
AHGWIDSTIK SGLKAARDVN RASQKPSRIQ LSNDNEL